Clinical Trial Update: Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial PALaDIN compares high-dose versus low-dose iron therapy to treat anemia in people on peritoneal dialysis; recruitment is currently ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease
• Iron Deficiency Anemia

Drugs mentioned

• High-dose intravenous iron
• Low-dose intravenous iron

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Peritoneal Dialysis, Anaemia | Phase 3 | Status: RECRUITING